Navigation Links
Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
Date:9/12/2011

SAN DIEGO, Sept. 12, 2011 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced that the Company will provide an update on the DIFICID™ (fidaxomicin) tablets launch at the Morgan Stanley Global Healthcare Conference taking place in New York City. Pedro Lichtinger, Optimer's President and CEO, will comment on the DIFICID launch tomorrow, September 13, during a webcasted fireside chat at 8:00 AM ET. DIFICID was approved by the U.S. Food and Drug Administration in May of 2011 for the treatment of Clostridium difficile-associated diarrhea (CDAD) in adults 18 years of age and older. CDAD is a significant medical problem in hospitals and long-term care facilities, and DIFICID is the first antibacterial drug approved for the treatment of CDAD in 25 years.

(Logo: http://photos.prnewswire.com/prnh/20090413/LA97352LOGO)

"We believe the Optimer strategy is proving highly impactful, with DIFICID sales exceeding published analyst expectations in the initial stages of the launch. While early in the launch, we view it as a major success to date. We are committed to maintaining this momentum as the launch matures," said Pedro Lichtinger, president and CEO of Optimer Pharmaceuticals. "The growing evidence of the value of DIFICID to patients, hospitals and payers  is being well received by practitioners and other stakeholders. Supported by DIFICID's clinical strength and value proposition, we believe the combined Optimer/Cubist field presence is having a material impact on accelerating prescriptions and formulary adoption."

There are several key components comprising the DIFICID launch effort and Optimer plans to review progress to date for each of those components.

1. DIFICID Sales

For the period of July 19, the date of DIFICID's first sales, through September 2 , Optimer estimates DIFICID gross sales of $
'/>"/>

SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
2. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
3. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
4. Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimers DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin
5. Optimer Pharmaceuticals Reports Second Quarter 2011 Financial Results
6. Optimer Launches DIFICID™ (fidaxomicin) Tablets for Treatment of Clostridium Difficile-Associated Diarrhea (CDAD) in Patients 18 Years of Age and Older
7. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8. Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
9. Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
10. Optimer Pharmaceuticals Expands Senior Management Team
11. Optimer Pharmaceuticals to Present at May 2011 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor ... nearly 800 doctors have recommended marijuana to the over 112,000 ... 20. But the majority of the other roughly 20,300+ active ... know very little about it – even though a poll ... adults say they have tried it. ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation ... U.S. District Court for the District of ... in the company,s case against Sandoz, Inc. regarding United ... Peter Sheridan ruled that U.S. Patent No. 6,765,117 ... enjoined Sandoz from marketing its generic product until the ...
(Date:8/29/2014)... , August 29, 2014 ... by Product & Services (Equipment, Reagent, Primer, Probe, ... (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) ... the global Oligonucleotide Synthesis Market is expected to ... in 2014, growing at a CAGR of 9.8% ...
Breaking Medicine Technology:Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4District Court Decision Received In Remodulin Patent Case 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4
(Date:8/31/2014)... Angeles, California (PRWEB) August 31, 2014 ... Randy Neil Clarito and brain fitness expert Tee Barr ... Center in Ventura City. Activities Director Virginia Ayala and ... their residents and patients attend this brain fitness session. ... in fighting and slowing down the development of dementia ...
(Date:8/31/2014)... 31, 2014 Asked to offer ... between "Bioavailability" and "absorption," Dr. Priya Khan, Director ... great interest. "Bioavailability" and "absorption" are possibly ... the supplement industry, second perhaps only to the ... and absorption, while related, are not the same. ...
(Date:8/31/2014)... a reliable review website, has recently compared many professional ... Hostgator are the best ASP.NET hosting suppliers of August ... the world, but good suppliers are not too many. ... server than running a Linux server, because it needs ... Arvixe and Hostgator are the most outstanding suppliers when ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 Ticket Down ... Bolivia tickets at Dick’s Sporting Goods Park in suburban ... a plethora of games against other international teams on USA ... Cup, Mexico brought a new soccer coach aboard, Miguel Herrera, ... In the build-up before the World Cup in Brazil, the ...
(Date:8/31/2014)... UT (PRWEB) August 31, 2014 ... supplement, sourced from organic fruits and berries, ... subscription) in all aspects tested, including purity and ... C supplements feature Ascorbic Acid from genetically modified ... entirely synthetic process. The process involves the use ...
Breaking Medicine News(10 mins):Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 2Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 3Health News:1Heart Caregiver Services Director Randy Neil Clarito Brings Brain Fitness Education to Victoria Care Center Ventura 4Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 2Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 3Health News:Bioavailability Vs Absorption - NutriGold Publishes Tips to Help Consumers Make Informed Decisions for Their Health 4Health News:Best ASP.NET Hosting Award for August 2014 Released By Top10BestSEOHosting.com 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO: Ticket Down Slashes Ticket Prices on Mexico vs. Bolivia Exhibition Game 3Health News:NutriGold’s Organic Wholefood-Sourced Vitamin C Gets ConsumerLab’s Seal of Approval 2Health News:NutriGold’s Organic Wholefood-Sourced Vitamin C Gets ConsumerLab’s Seal of Approval 3
... is becoming an elite disease as so much of research ... a result of such ongoing research, hyperhomocysteinemia (increased levels of ... risk factors.// ,Dr. O Mayer Jr and colleagues from ... of their study that beer may provide enough folate--a B ...
... may increase the risk of developing potentially harmful blood ... reported a case of 25 year old healthy male ... as subdural haematomas, after riding several roller coasters. ... vomiting, changes in mental abilities seizure and sometimes causes ...
... with type 1 diabetes reveal that they have more chances ... teens. ,The findings were based on study done on ... to 21 years, without type 1 diabetes. It was found ... regardless of body weight, family history, smoking and length of ...
... in every cigarette carton ,had been a useless tool to bring ... that even a single cigarette is enough to do the necessary ... is a well known fact that long term smoking has a ... etc.,. Dr. Firas A. Ghanem and colleagues at the ...
... CAP has been a therapeutic challenge to most of ... growing resistance of the bacteria causing them to the ... is highly effective in treating patients with pneumococcal bacteraemia ... in the field of anti microbials as pneumococcal resistance ...
... brain shrinkage in social drinkers. Chronic heavy alcohol consumption ... colleagues from Chiba University in Japan report in the ... Psychiatry. ,Alcohol, among the various forms insults both ... the brain according to the studies. ,Heavy alcohol ...
Cached Medicine News:
... potent glucocorticoid produced by the human ... is bound with high affinity to ... loosely bound to albumin. Cortisol acts ... in numerous physiologic systems, including immune ...
... or somatomedin C) is a 7.6 kDa peptide ... a potent mitogen of cellular proliferation, exerting its ... the circulation, IGF-I is bound to IGF-binding proteins ... IGF-I by modulating the interaction of IGF-I with ...
... somatomedin C) is a 7.6 kDa peptide produced ... potent mitogen of cellular proliferation, exerting its actions ... circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), ... by modulating the interaction of IGF-I with the ...
Urovac bladder evacuator with adaptor...
Medicine Products: